Moscow hospital group European Medical Center (EMC) still plans to IPO in around a year and is likely to list more than competitor MD Medical's 35% free float, we are told, while minority owner Baring Vostok will not completely exit.
London-listed Russian healthcare provider MD Medical Group (MDMG) began diversifying last year, as a flattening IVF market saw it looking elsewhere for growth.
The CEO of the last major foreign-invested private equity firm in Russia has been arrested on charges of "large-scale fraud". It is almost certain to hurt the sale processes of two of Russia's largest healthcare companies and further dampen whatever foreign investor interest is left in the country. Michael Calvey, who founded Baring Vostok in […]
HBI has just finished a deep dive into the rehabilitation sector. This small, fragmented, poor relative of acute care is often ignored by operators. A perception of low margins and a reluctance among acute hospitals to refer on to rehab cannot be helping. But things are changing, and new markets are opening up.
Russian lab group Citilab, once the second largest player on the market, has apparently seen a drop in revenue over the past three years. HBI investigates.
Russia has begun the long task of overhauling its Soviet-style nursing home stock by inviting private operators to build new homes. The sector has also begun to pilot regulatory reform that would require all homes to reach Western European standards of care. We speak to Senior Group, one of Russia's (comparatively) biggest high-end operators, about how the changes are opening up a market.
We hear the big Russian groups are moving away from IVF as the government funds the treatment at aggressively low tariffs, allowing public hospitals to encroach on market which has historically been the bedrock of the big private sector players. The IVF market in Russia stood at just under 30bn Rubles (€400m) in 2016 growing at […]
We talk to the Chairman of the Falck Vladivostok Hospital who says the international emergency care provider and co-investors are looking to sell and that there’s a bargain to be had for the willing buyer. Whilst an ambitious plan to build a Pan-Russian chain of budget hospitals was abandoned by the current investors, that plan could still offer an entree to the fast-growing Russian market.
Medicover's lab arm Synevo has acquired the Ukrainian diagnostics operations of Russian lab group Invitro for €6m, further sealing its dominant position.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy